Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy of the combination of mometasone furoate 0.1% and Salicylic Acid 5% in patients of both sexes who presented clinical symptoms of psoriasis of mild to moderate.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Azidus Brasil
• Treatments: Mometasone Furoate; Salicylates; Salicylic Acid

Criteria

Inclusion Criteria:

• Adults of both sexes, regardless of color or social class;

• Age 18 or older, with good mental health;

• Psoriasis patients with mild to moderate;

• Patients who agreed to participate and signed the

• Clarified (appendix);

• Patients who agreed to return for follow-up visits.

Exclusion Criteria:

• Patients who were making use of biologics, corticosteroids or nonsteroidal anti-inflammatory and non-steroid, or who made use of these topical medications until 15 days before inclusion or 30 days before inclusion when the administration was orally;

• Patients who were exposed to the sun 15 days before the study began or during the course of the same;

• Patients who were making use of acetaminophen;

• Patients who did not agree to the terms described in the IC informed consent, - Patients who also had psoriatic plaques of skin disorders caused by fungi or bacteria and they were making use of antibiotic or antifungal;

• Lions and other types of skin damage that was not psoriasis;

• Pregnant and nursing women;

• Patients using oral anticoagulants.